Arcutis Biotherapeutics, Inc. (ARQT)

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
ZORYVE Cream 0.3% Revenue	145.22M	121.00M	85.08M
ZORYVE Foam Revenue	254.80M	181.89M	71.54M
ZORYVE Cream 0.15% Revenue	97.72M	68.27M	9.92M
ZORYVE Cream 0.05% Revenue	-	911.00K	-
Total Product Revenue	506.68M	372.07M	166.54M
Other Segment Revenue	-	4.00M	30.00M
Revenue (Other)	2.00M	-911.00K	-
Revenue (Total)	508.68M	376.07M	196.54M

Data Source: Fiscal.ai Last updated: Nov 4, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 6, 2026

Data Sources Report a data error